Literature DB >> 17714104

Prospective, randomized, single-blind, sham treatment-controlled study of the safety and efficacy of an electromagnetic field device for the treatment of chronic low back pain: a pilot study.

R N Harden1, T A Remble, T T Houle, J F Long, M S Markov, M A Gallizzi.   

Abstract

OBJECTIVES: To evaluate the efficacy and safety of therapeutic electromagnetic fields (TEMF) on chronic low back pain. Secondary objectives included the investigation of the effects of TEMF on psychometric measures.
SETTING: Pain Research center in an Urban Academic Rehabilitation Facility.
DESIGN: Prospective, randomized, single-blind, placebo (sham) treatment-controlled design in which participants were evaluated over a 6-week period. A total of 40 subjects were randomly assigned: 20 subjects to 15 milliTESLA (mT) treatment using a prototype electromagnetic field device and 20 to sham treatment.
INTERVENTIONS: After a 2-week baseline period, eligible individuals were randomized to one of the treatment groups (sham or 15 mT) for six 30-minute treatments over 2 weeks, then a 2-week follow-up period. OUTCOME MEASURES: The primary outcome measure was the self-report of pain severity using a 100 mm visual analog scale collected using a twice daily McGill Pain Questionnaire-Short Form. Several secondary measures were assessed.
RESULTS: Both groups (15 mT and sham) improved over time (P < 0.05). Although groups were similar during the treatment period, treated subjects (TEMF of 15 mT) improved significantly over sham treatment during the 2-week follow-up period (20.5% reduction in pain; F(1,34) = 10.62, P = 0.003). There were no reported serious adverse events.
CONCLUSIONS: This study demonstrates that TEMF may be an effective and safe modality for the treatment of chronic low back pain disorders. More studies are needed to test this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714104     DOI: 10.1111/j.1533-2500.2007.00145.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  7 in total

Review 1.  Pulsed electromagnetic field therapy effectiveness in low back pain: A systematic review of randomized controlled trials.

Authors:  Renato Andrade; Hugo Duarte; Rogério Pereira; Isabel Lopes; Hélder Pereira; Rui Rocha; João Espregueira-Mendes
Journal:  Porto Biomed J       Date:  2016-11-01

2.  Electroacupuncture as a complement to usual care for patients with non-acute pain after back surgery: a study protocol for a pilot randomised controlled trial.

Authors:  Man-Suk Hwang; Kwang-Ho Heo; Hyun-Woo Cho; Byung-Cheul Shin; Hyeon-Yeop Lee; In Heo; Nam-Kwen Kim; Byung-Kwan Choi; Dong-Wuk Son; Eui-Hyoung Hwang
Journal:  BMJ Open       Date:  2015-02-04       Impact factor: 2.692

3.  Electromagnetic fields in the treatment of chronic lower back pain in patients with degenerative disc disease.

Authors:  Amarjit S Arneja; Alan Kotowich; Doug Staley; Randy Summers; Paramjit S Tappia
Journal:  Future Sci OA       Date:  2016-02-11

4.  Effects of pulsed low-frequency magnetic field therapy on pain intensity in patients with musculoskeletal chronic low back pain: study protocol for a randomised double-blind placebo-controlled trial.

Authors:  Fuad A Abdulla; Saad Alsaadi; Mir Sadat-Ali; Fahd Alkhamis; Hani Alkawaja; Serigne Lo
Journal:  BMJ Open       Date:  2019-06-09       Impact factor: 2.692

5.  Efficacy of Pulsed Low-Frequency Magnetic Field Therapy on Patients with Chronic Low Back Pain: A Randomized Double-Blind Placebo-Controlled Trial.

Authors:  Khalid Abdulkareem Alzayed; Saad Mohammed Alsaadi
Journal:  Asian Spine J       Date:  2019-10-04

6.  Evaluation of the Analgesic Efficacy of a Bioelectronic Device in Non-Specific Chronic Low Back Pain with Neuropathic Component. A Randomized Trial.

Authors:  Carlos de Teresa; Alfonso Varela-López; Susana Rios-Álvarez; Rafael Gálvez; Coralie Maire; Santos Gracia-Villar; Maurizio Battino; José L Quiles
Journal:  J Clin Med       Date:  2021-04-20       Impact factor: 4.241

7.  Rotating magnetic field ameliorates experimental autoimmune encephalomyelitis by promoting T cell peripheral accumulation and regulating the balance of Treg and Th1/Th17.

Authors:  Tianying Zhan; Xiaomei Wang; Zijun Ouyang; Youli Yao; Jiangyao Xu; Shikang Liu; Kan Liu; Qiyu Deng; Yushu Wang; Yingying Zhao
Journal:  Aging (Albany NY)       Date:  2020-04-07       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.